Stockscreener 앱 받기
3.05
2.24%
-0.07
전일 마감가:
$3.12
열려 있는:
$3.07
하루 거래량:
24,697
Relative Volume:
0.27
시가총액:
$26.54M
수익:
-
순이익/손실:
$-4.08M
주가수익비율:
-2.5938
EPS:
-1.1759
순현금흐름:
$-2.58M
1주 성능:
+3.39%
1개월 성능:
-8.68%
6개월 성능:
-24.88%
1년 성능:
+117.86%
1일 변동 폭
$3.05
$3.20
1주일 범위
$2.45
$3.2399
52주 변동 폭
$0.64
$6.26
Lixte Biotechnology Holdings Inc Stock (LIXT) Company Profile
명칭
Lixte Biotechnology Holdings Inc
전화
310 203 2902
주소
433 PLAZA REAL, BOCA RATON
Compare LIXT vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LIXT
Lixte Biotechnology Holdings Inc
|
3.05 | 27.15M | 0 | -4.08M | -2.58M | -1.1759 |
|
VRTX
Vertex Pharmaceuticals Inc
|
491.47 | 117.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
803.17 | 82.85B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
821.96 | 51.58B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
314.40 | 40.75B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.07 | 38.33B | 4.98B | 69.60M | 525.67M | 0.5198 |
Lixte Biotechnology Holdings Inc 주식(LIXT)의 최신 뉴스
Why is Lixte Biotechnology Holdings Inc. stock going downRate Cut & Step-by-Step Swing Trade Plans - mfd.ru
LIXTE Biotechnology (LIXT) Bringing First-in-Class Approach to Chemo and Immunotherapy - NewMediaWire
LIXTE Biotechnology (NASDAQ: LIXT) Bringing First-in-Class Approach to Chemo and Immunotherapy - Digital Journal
Can Lixte Biotechnology Holdings Inc. Equity Warrant be recession proofTrade Ideas & Short-Term High Return Strategies - mfd.ru
How is Lixte Biotechnology Holdings Inc. managing supply chain issuesWeekly Trade Recap & Capital Protection Trading Alerts - mfd.ru
Why Lixte Biotechnology Holdings Inc. stock could rally in 2025Volume Spike & Weekly Momentum Picks - mfd.ru
How Lixte Biotechnology Holdings Inc. Equity Warrant stock compares to growth peersWeekly Profit Report & AI Driven Stock Price Forecasts - mfd.ru
LIXTE Biotechnology (LIXT) Aligns Liora and LiGHT System With LB-100 to Push Frontier of Cancer Treatment - NewMediaWire
LIXTE Biotechnology (NASDAQ: LIXT) Aligns Liora and LiGHT System With LB-100 to Push Frontier of Cancer Treatment - Digital Journal
LIXTE Biotechnology (LIXT) Positions LB-100 to Expand Effectiveness of Standard Cancer Treatment - Yahoo Finance
LIXTE Biotechnology (NASDAQ: LIXT) Positions LB-100 to Expand Effectiveness of Standard Cancer Treatment - Digital Journal
Earnings Miss: Will Lixte Biotechnology Holdings Inc Equity Warrant stock benefit from M AMarket Activity Report & High Accuracy Investment Entry Signals - baoquankhu1.vn
Ideas Watch: What is the next catalyst for Lixte Biotechnology Holdings Inc Equity WarrantTake Profit & Stepwise Trade Signal Implementation - baoquankhu1.vn
Improving the Odds: How LIXTE Biotechnology (NASDAQ: LIXT) Is Working to Make Cancer Therapies More Effective - The Globe and Mail
Earnings Miss: Is Lixte Biotechnology Holdings Inc stock forming a triangle pattern2025 Retail Activity & Daily Profit Maximizing Trade Tips - baoquankhu1.vn
LIXTE Biotechnology Targets Cancer Treatment Resistance with PP2A Inhibitor Platform - citybuzz -
Improving the Odds: How LIXTE Biotechnology (LIXT) Is Working to Make Cancer Therapies More Effective - NewMediaWire
Market Overview: What makes Lixte Biotechnology Holdings Inc. Equity Warrant stock attractive todayJuly 2025 Breakouts & Safe Capital Growth Plans - baoquankhu1.vn
Is Lixte Biotechnology Holdings, Inc. overvalued or undervalued? - Markets Mojo
Retail Trends: Is Lixte Biotechnology Holdings Inc a stock for growth or value investors2025 Analyst Calls & AI Powered Buy and Sell Recommendations - baoquankhu1.vn
LIXTE Biotechnology Holdings (LIXT) Advances a Novel Approach to Enhancing Cancer Therapy - NewMediaWire
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
DealFlow Discovery Conference Announces Initial Lineup of Presenting Companies Ahead of Next Week's Event - The Globe and Mail
LIXTE Biotechnology Holdings (NASDAQ: LIXT) Advances a Novel Approach to Enhancing Cancer Therapy - Digital Journal
Datavault AI (NASDAQ: DVLT) Closes Acquisition of API Media Innovation - financial-news.co.uk
De La Soul Set to Lead Good Health Summit at Morehouse College - EBONY Magazine
Stop Loss: Can C3is Inc weather a recessionEarnings Overview Summary & Safe Capital Growth Plans - baoquankhu1.vn
LIXTE Biotechnology Advances Novel Cancer Therapy Approach Targeting PP2A Enzyme - citybuzz -
Spartan Capital Securities, LLC Proudly Serves as Placement Agent in Lixte Biotechnology Holdings, Inc.'s $4.3 Million Registered Direct Offering - Big News Network.com
Highs Report: What makes Lixte Biotechnology Holdings Inc Equity Warrant stock attractive today2025 Growth vs Value & AI Powered Market Entry Ideas - baoquankhu1.vn
Is Lixte Biotechnology Holdings Inc stock a value trapFed Meeting & AI Forecasted Entry and Exit Points - baoquankhu1.vn
LIXTE Biotechnology Holdings (LIXT) Sponsors Good Health Mind, Body and Soul Summit - Yahoo Finance
LIXTE Biotechnology Holdings (NASDAQ: LIXT) Sponsors Good Health Mind, Body and Soul Summit - Digital Journal
LIXTE Biotechnology Sponsors Health Equity Summit at Morehouse College, Linking Cancer Research to Community Wellness - citybuzz -
De La Soul's 'Good Health' summit targets Black men's wellness - Stock Titan
DE LA SOUL-LED “GOOD HEALTH SUMMIT” LAUNCHES FEBRUARY 19 AT MOREHOUSE COLLEGE - The Globe and Mail
Lixte Biotechnology to Present at DealFlow Discovery Conference as Clinical Trials Advance - citybuzz -
LIXTE Biotechnology Attending the DealFlow Discovery Conference, January 28-29 - manilatimes.net
How Lixte Biotechnology Holdings Inc. stock compares to growth peersSector Performance Review & Rapid Portfolio Trading - Bollywood Helpline
Is Lixte Biotechnology Holdings Inc. a stock for growth or value investorsQuarterly Earnings Summary & Real-Time Volume Trigger Notifications - bollywoodhelpline.com
Breakout Move: Can Arvinas Inc grow without external fundingJuly 2025 Spike Watch & Precise Buy Zone Identification - baoquankhu1.vn
Aug Movers: Is OPAD a play on infrastructure spending2025 Trade Ideas & Expert Approved Trade Ideas - baoquankhu1.vn
Pullback Watch: Whats the profit margin of Lixte Biotechnology Holdings IncJuly 2025 Action & Growth Oriented Trading Recommendations - baoquankhu1.vn
Institution Moves: How Lixte Biotechnology Holdings Inc stock performs after earningsJuly 2025 Market Mood & Low Volatility Stock Suggestions - Bộ Nội Vụ
LIXTE Biotechnology Engages IBN to Amplify Communications for Cancer Therapy Development - citybuzz -
About Us - FinancialContent
LIXTE Biotechnology (LIXT) Enhances Visibility with New Communications Strategy - GuruFocus
IBN Initiates Coverage of LIXTE Biotechnology Holdings Inc. - The Manila Times
Breakout Zone: Can Lixte Biotechnology Holdings Inc Equity Warrant withstand a market correctionPortfolio Gains Summary & Low Risk High Win Rate Stock Picks - baoquankhu1.vn
Weekly Trades: How Lixte Biotechnology Holdings Inc stock compares to growth peersEarnings Performance Report & Real-Time Buy Signal Notifications - Bộ Nội Vụ
Is Lixte Biotechnology Holdings Inc. stock trading at a premium valuationTreasury Yields & Expert-Curated Trade Recommendations - ulpravda.ru
Lixte Biotechnology Holdings Inc (LIXT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.12%
0.87%
자본화:
|
볼륨(24시간):